Buss DH - Search Results

1

The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases.

Buss DH, Stuart JJ, Lipscomb GE. Buss DH, et al. Am J Hematol. 1985 Dec;20(4):365-72. doi: 10.1002/ajh.2830200408. Am J Hematol. 1985. PMID: 3865532

2

Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases.

Buss DH, Cashell AW, O'Connor ML, Richards F 2nd, Case LD. Buss DH, et al. Am J Med. 1994 Mar;96(3):247-53. doi: 10.1016/0002-9343(94)90150-3. Am J Med. 1994. PMID: 8154513

3

The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.

Cashell AW, Buss DH. Cashell AW, et al. Among authors: buss dh. Ann Hematol. 1992 Jun;64(6):273-6. doi: 10.1007/BF01695470. Ann Hematol. 1992. PMID: 1637881

4

Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.

Buss DH, O'Connor ML, Woodruff RD, Richards F 2nd, Brockschmidt JK. Buss DH, et al. Arch Pathol Lab Med. 1991 May;115(5):475-80. Arch Pathol Lab Med. 1991. PMID: 2021316

5

An incidental finding of extreme self-limited thrombocytosis of unknown cause.

Cashell AW, Buss DH, Johnson CA. Cashell AW, et al. Among authors: buss dh. W V Med J. 1993 Dec;89(12):545-6. W V Med J. 1993. PMID: 8128657

6

The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients.

Kute TE, Muss HB, Cooper MR, Case LD, Buss D, Stanley V, Gregory B, Galleshaw J, Booher K. Kute TE, et al. Cancer. 1990 Oct 15;66(8):1810-6. doi: 10.1002/1097-0142(19901015)66:8<1810::aid-cncr2820660828>3.0.co;2-0. Cancer. 1990. PMID: 2208036

7

Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study.

Abruzzese E, Buss D, Rainer R, Pettenati MJ, Rao PN. Abruzzese E, et al. Ann Hematol. 1996 Jul;73(1):35-8. doi: 10.1007/s002770050197. Ann Hematol. 1996. PMID: 8695722

8

Immunoglobulin D benign monoclonal gammopathy. A case report.

O'Connor ML, Rice DT, Buss DH, Muss HB. O'Connor ML, et al. Among authors: buss dh. Cancer. 1991 Aug 1;68(3):611-6. doi: 10.1002/1097-0142(19910801)68:3<611::aid-cncr2820680328>3.0.co;2-5. Cancer. 1991. PMID: 1905973 Review.

9

Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: an analysis of 208 cases.

Sexton C, Buss D, Powell B, O'Connor M, Rainer R, Woodruff R, Cruz J, Pettenati M, Rao PN, Case LD. Sexton C, et al. Leuk Res. 1996 Jun;20(6):467-72. doi: 10.1016/0145-2126(96)00001-x. Leuk Res. 1996. PMID: 8709618

10

Low dose Ara-C for patients with myelodysplastic syndromes.

Powell BL, Capizzi RL, Jackson DV, Richards F, Muss HB, Lyerly ES, Rosenbaum DL, Connelly RA, Buss DH, Bearden JD, et al. Powell BL, et al. Among authors: buss dh. Leukemia. 1988 Mar;2(3):153-6. Leukemia. 1988. PMID: 3347093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page